Genomic data from a pharmacogenetic study based on the efficacy of Tocilizumab in severe COVID-19 patients

  1. Rego-Perez, Ignacio
  2. Alejandro, Durán-Sotuela
  3. Jorge, Vázquez-García
  4. Sara, Relaño-Fernández
  5. Vanesa, Balboa-Barreiro
  6. Juan, Fernández-Tajes
  7. Francisco J, Blanco

Editor: Zenodo

Año de publicación: 2024

Tipo: Dataset

CC BY 4.0

DOI: 10.5281/ZENODO.13692512 lock_openAcceso abierto editor

Resumen

These data correspond to a pharmacogenetic study aimed to explore genetic associations related to the efficacy of Tocilizumab in severe COVID-19 patients. The study comprised two sets of patients, an initial subset consisted of 425 patients to whom a in-dpeth sequencing of a thermofisher sequencing panel of immune-related genes was performed, as well as a second set of 245 patients with the information of the genotyping of three selected SNPs